Jae Park, MD, discusses his key takeaways from chimeric antigen receptor T cells in the treatment landscape of patients with acute lymphoblastic leukemia.
Videos
Linda Bosserman, MD, discusses the emerging role of telehealth and the challenges with implementing this type of care into cancer centers in the United States.
Joyce A. O'Shaughnessy, MD, discusses the phase II plasmaMATCH trial, which investigated plasma-based molecular profiling of patients with advanced breast cancer to inform therapeutic choices.
Experts in breast oncology review 4 clinical cases and discuss individualized treatment approaches for each patient.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
2
ctDNA Refines Risk in Neoadjuvant-Resistant Breast Cancer
3
Illuminating the Sequence of Third-Line Therapies in Metastatic CRC
4
High Survival Seen with Nogapendekin Alfa Inbakicept in Papillary NMIBC
5